Berry GenomicsLtd Yönetim

Yönetim kriter kontrolleri 2/4

Berry GenomicsLtd's CEO is Yang Gao, appointed in Sep 2021, has a tenure of 3.17 years. directly owns 9.08% of the company’s shares, worth CN¥285.56M. The average tenure of the management team and the board of directors is 2.8 years and 1.7 years respectively.

Anahtar bilgiler

Yang Gao

İcra Kurulu Başkanı

CN¥1.2m

Toplam tazminat

CEO maaş yüzdesi	n/a
CEO görev süresi	3.2yrs
CEO sahipliği	9.1%
Yönetim ortalama görev süresi	2.8yrs
Yönetim Kurulu ortalama görev süresi	1.7yrs

Son yönetim güncellemeleri

Recent updates

Berry Genomics Co.,Ltd (SZSE:000710) Shares Fly 26% But Investors Aren't Buying For Growth

May 21

Berry Genomics Co.,Ltd (SZSE:000710) Held Back By Insufficient Growth Even After Shares Climb 32%

Mar 08

CEO

Yang Gao (44 yo)

3.2yrs

Görev süresi

CN¥1,224,600

Tazminat

Dr. Yang Gao is Chairman at Berry Genomics Co., Ltd. and Director since July 20, 2017 and serves as its General Manager since September 30, 2021. He served as Acting Chief Financial Officer at Berry Genomi...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Yang Gao	GM & Chairman	3.2yrs	CN¥1.22m	9.08% CN¥ 285.6m
Daixing Zhou	Co-Founder & Chief Scientist	no data	CN¥1.43m	0.13% CN¥ 4.0m
Dong Wang	CFO, Deputy GM & Director	1.3yrs	CN¥446.30k	Veri yok
Wenlu Ai	Secretary	2.8yrs	CN¥578.40k	Veri yok
Li Gao	Accounting Supervisor	no data	Veri yok	Veri yok

2.8yrs

Ortalama Görev Süresi

47.5yo

Ortalama Yaş

Deneyimli Yönetim: 000710's management team is considered experienced (2.8 years average tenure).

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Yang Gao	GM & Chairman	7.3yrs	CN¥1.22m	9.08% CN¥ 285.6m
Dong Wang	CFO, Deputy GM & Director	1.3yrs	CN¥446.30k	Veri yok
Hongxia Wang	Director	7.3yrs	Veri yok	Veri yok
Hong Yan Chen	Supervisor	4.3yrs	Veri yok	Veri yok
Dake Zhang	Independent Director	1.3yrs	CN¥33.30k	Veri yok
Hui Zhao	Director	1.3yrs	CN¥33.30k	Veri yok
Shiyang Hu	Independent Director	1.3yrs	CN¥33.30k	Veri yok
Yao Li	Independent Director	2.1yrs	CN¥80.00k	Veri yok
Xiangdong Li	Chairman of the Supervisory Board	1.3yrs	Veri yok	Veri yok
Zhichao Wang	Employee Supervisor	2.3yrs	Veri yok	Veri yok

1.7yrs

Ortalama Görev Süresi

46yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: 000710's board of directors are not considered experienced ( 1.7 years average tenure), which suggests a new board.

Berry GenomicsLtd Yönetim

Yönetim kriter kontrolleri 2/4

Anahtar bilgiler

Son yönetim güncellemeleri

Berry Genomics Co.,Ltd, Annual General Meeting, May 17, 2024

High number of new and inexperienced directors

Less than half of directors are independent

Berry Genomics Co.,Ltd, Annual General Meeting, May 09, 2022

Recent updates

Third quarter 2024 earnings released: EPS: CN¥0.003 (vs CN¥0.11 loss in 3Q 2023)

Berry Genomics Co.,Ltd to Report Q3, 2024 Results on Oct 29, 2024

Second quarter 2024 earnings released: EPS: CN¥0.003 (vs CN¥0.21 loss in 2Q 2023)

Berry Genomics Co.,Ltd to Report First Half, 2024 Results on Aug 23, 2024

Berry Genomics Co.,Ltd (SZSE:000710) Shares Fly 26% But Investors Aren't Buying For Growth

Berry Genomics Co.,Ltd, Annual General Meeting, May 17, 2024

First quarter 2024 earnings released: EPS: CN¥0.02 (vs CN¥0.06 loss in 1Q 2023)

Berry Genomics Co.,Ltd to Report Q1, 2024 Results on Apr 25, 2024

Berry Genomics Co.,Ltd (SZSE:000710) Held Back By Insufficient Growth Even After Shares Climb 32%

New minor risk - Share price stability

High number of new and inexperienced directors

Second quarter 2023 earnings released: CN¥0.21 loss per share (vs CN¥0.021 loss in 2Q 2022)

Berry Genomics Co.,Ltd to Report First Half, 2023 Results on Aug 16, 2023

Full year 2022 earnings released: CN¥0.82 loss per share (vs CN¥0.31 loss in FY 2021)

Berry Genomics Co.,Ltd(XSEC:000710) dropped from S&P Global BMI Index

Less than half of directors are independent

Third quarter 2022 earnings released: EPS: CN¥0.005 (vs CN¥0.009 loss in 3Q 2021)

Second quarter 2022 earnings released: CN¥0.021 loss per share (vs CN¥0.028 profit in 2Q 2021)

Berry Genomics Co.,Ltd, Annual General Meeting, May 09, 2022

First quarter 2022 earnings: EPS and revenues miss analyst expectations

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Third quarter 2021 earnings released: CN¥0.009 loss per share (vs CN¥0.094 profit in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.028 (vs CN¥0.16 in 2Q 2020)

Investor sentiment improved over the past week

Full year 2020 earnings released: EPS CN¥0.63 (vs CN¥1.10 in FY 2019)

Investor sentiment deteriorated over the past week

Twist Bioscience Corporation and Berry Genomics to Offer New NGS Solution to Advance Research and Precision Medicine

Investor sentiment improved over the past week

New 90-day low: CN¥30.79

Investor sentiment deteriorated over the past week

New 90-day low: CN¥35.06

New 90-day low: CN¥40.65

New 90-day low: CN¥47.99

Third quarter 2020 earnings released: EPS CN¥0.095

New 90-day low: CN¥52.05

New 90-day low - CN¥53.40

First half earnings released

Berry Genomics Co.,Ltd announced that it expects to receive CNY 2.1355806 billion in funding

Berry Genomics Co.,Ltd to Report First Half, 2020 Results on Aug 31, 2020

New 90-day high - CN¥70.63

CEO

Görev süresi

Tazminat

Liderlik Ekibi

Ortalama Görev Süresi

Ortalama Yaş

Yönetim Kurulu Üyeleri

Ortalama Görev Süresi

Ortalama Yaş